Pathology & Oncology Research | Toxicity of Pharmaceutical Treatments in Pediatric Leukemia and Lymphoma Cases

Toxicity of Pharmaceutical Treatments in Pediatric Leukemia and Lymphoma Cases

Articles

CASE REPORT

Published on 12 Sep 2022

Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion

Egle Stukaite-Ruibiene
Rimvydas Norvilas
Vaidas Dirse
Sigita Stankeviciene
Goda Elizabeta Vaitkeviciene

Case Report: Specific ABL-Inhibitor Imatinib Is an Effective Targeted Agent as the First Line Therapy to Treat B-Cell Acute Lymphoblastic Leukemia With a Cryptic NUP214::ABL1 Gene Fusion

doi 10.3389/pore.2022.1610570

2 citations

CASE REPORT

Published on 12 Aug 2022

Case Report: Brentuximab Vedotin Associated Acute Pancreatitis in a Pediatric Hodgkin Lymphoma Patient: Case Report and Literature Review

Ewelina Truszkowska
Marta Andrzejewska
Cyntia Szymańska
Agnieszka Wziątek
Katarzyna Derwich

Case Report: Brentuximab Vedotin Associated Acute Pancreatitis in a Pediatric Hodgkin Lymphoma Patient: Case Report and Literature Review

doi 10.3389/pore.2022.1610445

3 citations

BRIEF RESEARCH REPORT

Published on 31 Mar 2022

Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary

Judit Müller
Dóra Szűcs-Farkas
István Szegedi
Monika Csóka
Miklós Garami
Lilla Györgyi Tiszlavicz
Péter Hauser
Gergely Kriván
Krisztina Csanádi
3 more
Gábor Kovács

Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary

doi 10.3389/pore.2022.1610261

9 citations

Share on

Pathology and Oncology Research

Pathology and Oncology Research

Manuscripts can be submitted to this Special Issue via the main journal or any other participating journal.